Kayentis

Kayentis

Fabrication de produits pharmaceutiques

Meylan, Auvergne-Rhone-Alpes 7 158 abonnés

Simplify your clinical trial experience

À propos

Kayentis, a global provider of eCOA (electronic Clinical Outcome Assessment) and Decentralized Clinical Trial solutions (DCTs), helps pharma, biotech and CROs bring simplicity, efficiency and quality to the collection of clinical trial data from both patients and sites. Since 2005, Kayentis has been active in clinical development, with a strong specialization in eCOA solutions for phases I-IV across a broad range of therapeutic areas. Over the years, it has developed a full range of services and has enlarged its portfolio beyond eCOA solutions to support the new normal of decentralized and hybrid trials. The company has conducted digital data collection for over 300 clinical trials in 90 countries (100,000 patients), employing 120 languages. It has offices in the US (Boston), France (Grenoble) and Japan (Tokyo), and currently employs 185 staff.

Secteur
Fabrication de produits pharmaceutiques
Taille de l’entreprise
51-200 employés
Siège social
Meylan, Auvergne-Rhone-Alpes
Type
Société civile/Société commerciale/Autres types de sociétés
Fondée en
2003
Domaines
eCOA solutions, Patient engagement, Electronic Clinical Outcome Assessments, Clinical Trials, ePRO, ClinRO, ObsRO, PerfO, eDiary, PRO, DCT solutions, BYOD et Televisit

Lieux

Employés chez Kayentis

Nouvelles

Pages similaires

Parcourir les offres d’emploi

Financement

Kayentis 8 rounds en tout

Dernier round

Série inconnue

2 384 547,00 $US

Voir plus d’informations sur Crunchbase